Cost Effectiveness of Peginterferon ??-2a Plus Ribavirin versus Interferon ??-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 22 (4) , 257-265
- https://doi.org/10.2165/00019053-200422040-00004
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Introduction to therapy of hepatitis CHepatology, 2002
- Combination of interferon induction therapy and ribavirin in chronic hepatitis CHepatology, 2001
- Estimating progression to cirrhosis in chronic hepatitis C virus infectionHepatology, 2001
- Cost-effectiveness of combination therapy for naive patients with chronic hepatitis CNoteJournal of Hepatology, 2000
- Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis CHepatology, 2000
- Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis CHepatology, 1999
- The Long–Term Pathological Evolution of Chronic Hepatitis CHepatology, 1996
- Liver transplantation for hepatitis C virus-related cirrhosisHepatology, 1994
- Liver transplantation for hepatitis C virus-related cirrhosisHepatology, 1994
- AN ANALYSIS OF LIVER TRANSPLANT EXPERIENCE FROM 37 TRANSPLANT CENTERS AS REPORTED TO MEDICARETransplantation, 1993